Target intelligence / Profile preview

Terminal uridylate transferase 7 (TUT7)

Target
TUT7
Molecular classification
Enzyme, Transferase, Nucleotidyltransferase, RNA-modifying enzyme
01

Overview

Terminal uridylate transferase 7 (TUT7), also known as ZCCHC6, is a member of the poly(A) polymerase family that functions as a non-canonical nucleotidyltransferase [UniProt: Q5VYS8]. It primarily catalyzes the template-independent addition of uridine residues to the 3' ends of various RNA molecules, a process termed uridylation [PubMed: 25480299]. This modification acts as a molecular switch, often signaling for RNA degradation via the DIS3L2 exonuclease or modulating the processing of microRNAs, such as the let-7 family [PubMed: 24332040]. In oncology, TUT7 is frequently overexpressed and contributes to the downregulation of tumor-suppressive miRNAs, thereby promoting cell proliferation and metastasis [PubMed: 30104381]. Additionally, TUT7 has been identified as a factor in viral replication, where it can either restrict or facilitate viral RNA stability depending on the pathogen [PubMed: 28216319]. While no clinical-stage drugs currently target TUT7, it is an active area of research for small-molecule inhibition to restore RNA homeostasis in cancer and infectious diseases [PubMed: 32619401].

Other names
ZCCHC6Terminal uridylyltransferase 7RNA uridylyltransferase ZCCHC6
02

Mechanism of action

Inhibition of TUT7-mediated uridylation to prevent the degradation of tumor-suppressive miRNAs or to destabilize viral RNA transcripts.

03

Biological functions

RNA uridylationmRNA degradationmiRNA processingRNA stability regulation
04

Disease associations

CancerViral infectionInflammation
05

Safety considerations

Potential disruption of global RNA homeostasisOff-target effects on essential mRNA decay pathwaysPotential systemic toxicity due to broad tissue expression
06

Biomarkers

TUT7 mRNA expression levelsTUT7 protein expression levelsUridylation status of let-7 miRNA

Beyond the preview

Go deeper on Terminal uridylate transferase 7 (TUT7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Terminal uridylate transferase 7 (TUT7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call